Cogan syndrome - Pathogenesis, clinical variants and treatment approaches

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 351-354

  Kessel, Aharon ^a   Vadasz, Zahava ^a   Toubi, Elias ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Autoimmune hearing loss; Cogan syndrome; Episcleritis; Vasculitis

Indexed keywords

ANTIBODY; ANTIGEN; ATROPINE; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOPLEGIC AGENT; CYCLOSPORIN; CYCLOSPORIN A; CYTOTOXIC AGENT; ENDOTHELIAL CELL ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLIXIMAB; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RITUXIMAB; STEROID; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABDOMINAL PAIN; APHASIA; ATAXIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COCHLEA PROSTHESIS; COGAN SYNDROME; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; DIARRHEA; DISEASE CLASSIFICATION; EYE INFLAMMATION; HEARING IMPAIRMENT; HEMIPARESIS; HEMIPLEGIA; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR; KERATITIS; LABORATORY TEST; MELENA; NEUROLOGIC DISEASE; OSCILLOPSIA; PATHOGENESIS; PREVALENCE; PROGNOSIS; REMISSION; REVIEW; RISK FACTOR; STEROID THERAPY; SYSTEMIC DISEASE; SYSTEMIC VASCULITIS; TINNITUS; TREATMENT INDICATION; TREATMENT RESPONSE; VASCULITIS; VERTIGO; WESTERN BLOTTING;

AUTOIMMUNE HEARING LOSS; COGAN SYNDROME; EPISCLERITIS; VASCULITIS;

ADRENAL CORTEX HORMONES; AUTOANTIBODIES; COGAN SYNDROME; EAR, INNER; HUMANS; KERATITIS;

EID: 84896318817     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.002     Document Type: Review

References (39)

1. Morgan R.F., Baumgartner C.F. Menier's disease complicated by recurrent interstitial keratitis. West J Surg 1934, 42:628.
2. Cogan D.G. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 1945, 33:144-149.
3. Bennett F.M. Bilateral recurrent episcleritis associated with posterior corneal changes, vestibuloauditory symptoms and rheumatoid arthritis. Am J Ophthalmol 1963, 55:8158.
4. Cherson B.D., Bluming A.Z., Alroy J. Cogan's syndrome: a systemic vasculitis. Am J Med 1976, 60:549-555.
5. EW St.Clair, McCallum R.M. Cogan's syndrome. Curr Opin Rheumatol 1999, 11:47-52.
6. Arnold W., Gebbers J.O. Serum antibodies against corneal and internal ear tissues in Cogan's syndrome. Laryngol Rhinol Otol (Stuttg) 1984, 63:428-432.
7. Arnold W., Pfaltz R., Altermatt H.J. Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders. Acta Otolaryngol 1985, 99:437-444.
8. Helmchen C., Arbusow V., Jager L., Strupp M., Stocker W., Schlz P. Cogan's syndrome: clinical significance of antibodies against the inner ear and cornea. Acta Otolaryngol 1999, 119:528-536.
9. Naumann A., Hempel J.M., Schorn K. Detection of immune response to the inner ear proteins in patients with sensorineural hearing loss. Laryngorhinootologie 2001, 80:237-244.
10. Lunardi C., Bason C., Leandri M., Navone R., Lestani M., Millo E., et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002, 360:915-921.
11. Berti E., Vannucci G., Lunardi C., Bianchi B., Bason C., Puccetti A., et al. Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. Autoimmunity 2013, 46:525-530.
12. Lepse N., Abdulahad W.H., Kallenberg C.G., Heeringa P. Immune regulatory mechanisms in ANCA-associated vasculitis. Autoimmun Rev 2011, 11:77-83.
13. Vollersten R. Vasculitis and Cogan's syndrome. Rheum Dis Clin North Am 1990, 16:433-438.
14. Greco A., Gallo A., Fusconi M., Magliulo G., Turchetta R., Marinelli C., et al. Cogan's syndrome: an autoimmune inner ear disease. Autoimmun Rev 2013, 12:396-400.
15. Vollertsen R.S., McDonald T.J., Younge B.R., Banks P.M., Stanson A.W., Ilstrup D.M. Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986, 61:344-361.
16. Haynes B.F., Kaiser-Kupfer M.I., Mason P., Fauci A.S. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine 1980, 59:426-441.
17. Gluth M.B., Baratz K.H., Matteson E.L., Driscoll C.L.W. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 2006, 81(4):483-488.
18. Cheson B.D., Bluming A.Z., Alroy J. Cogan's syndrome: a systemic vasculitis. Am J Med 1976, 60:549-555.
19. Ferrari E., Taillan B., Garnier G., Dor V., Morand P., Dujardin P. Manifestations cardiovasculaires du syndrome de Cogan. A propos d'un cas. Arch Mal Coeur 1992, 85:913-916.
20. Grasland A., Pouchot J., Hachulla E., Bletry O., Papo T., Vinceneux P. Study group for Cogan's syndrome. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 2004, 43(8):1007-1015.
21. Gaubitz M., Lubben B., Seidel M., Schotte H., Gramley F., Domschke W. Cogan's syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature. Clin Exp Rheumatol 2001, 19(4):463-469.
22. Bicknell J.M., Holland J.V. Neurologic manifestations of Cogan's syndrome. Neurology 1978, 28:278-281.
23. Chynn E.W., Jacobiec F.A. Cogan's syndrome: ophthalmic, audiovestibular, and systemic manifestations and therapy. Int Ophthalmol Clin 1996, 36:61-72.
24. Ho A.C., Roat M.I., Venbrux A., Hellmann D.B. Cogan's syndrome with refractory aortitis and mesenteric vasculitis. J Rheumatol 1999, 26:1404-1407.
25. Van Doornum S., McColl G., Walter M., Jennens I., Bhathal P., Wicks I.P. Prolonged prodrome, systemic vasculitis, and deafness in Cogan's syndrome. Ann Rheum Dis 2001, 60:69-71.
26. Broughton S.S., Meyerhoff W.E., Cohen S.B. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 2004, 34:544-548.
27. Shimura M., Yasuda K., Fuse N., Nakazawa M., Tamai M. Effective treatment with topical cyclosporin A of a patient with Cogan syndrome. Ophthalmologica 2000, 214:429-432.
28. Haynes B.F., Pikus A., Kaiser-Kupfer M., Fauci A.S. Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids. Arthritis Rheum 1981, 24:501-503.
29. Allen N.B., Cox C.C., Cobo M., Kisslo J., Jacobs M.R., McCallum R.M., et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med 1990, 88:296-301.
30. Riente L., Taglione E., Berrettini S. Efficacy of methotrexate in Cogan's syndrome. J Rheumatol 1996, 23:1830-1831.
31. Touma Z., Nawwar R., Hadi U., Hourani M., Arayssi T. The use of TNF-alpha blockers in Cogan's syndrome. Rheumatol Int 2007, 27:995-996.
32. Weyn T., Haine S., Conraads V. Cogan's syndrome with left main coronary artery occlusion. Cardiol J 2009, 16:573-576.
33. Ghadban R., Couret M., Zenone T. Efficacy of infliximab in Cogan's syndrome. J Rheumatol 2008, 35:2456-2458.
34. Fricker M., Baumann A., Wermelinger F., Villiger P.M., Helbling A. A novel therapeutic option in Cogan disease? TNF-alpha blockers. Rheumatol Int 2007, 27:493-495.
35. Shibuya M., Fujio K., Morita K., Harada H., Kanda H., Yamamoto K. Successful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis. Mod Rheumatol 2013, 23(3):577-581.
36. Orsoni J.G., Laganà B., Rubino P., Zavota L., Bacciu S., Mora P. Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report. Orphanet J Rare Dis 2010, 16:5-18.
37. Minet M., Deggouj N., GersdorV M. Cochlear implantation in patients with Cogan's syndrome: a review of four cases. Eur Arch Otorhinolaryngol 1997, 254:459-462.
38. Aschendor V.A., Lohnstein P., Schipper J., Klenzner T. Obliterated cochlea in Cogan's syndrome-implications for cochlear implant surgery. Laryngorhinootologie 2004, 83(12):836-839.
39. Cinamon U., Kronenberg J., Hildesheimer M., Taitelbaum R. Cochlear implantation in patients suffering from Cogan's syndrome. J Laryngol Otol 1997, 111(10):928-930.